ABUS

Arbutus Biopharma CorporationNASDAQHealthcare

$4.48-0.88%ClosedMarket Cap: $875.7M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-11-14	Chardan Capital	—	Buy	—
2025-08-11	Chardan Capital	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-0.16	$1.0M	1
Fri Dec 31	$-0.05	$8.8M	1
Sun Dec 31	$-0.14	$55.9M	1
Mon Dec 31	$0.34	$173.5M	1